ASTC ASTROTECH Corp
$7.25 +4.09%
Updated
Healthcare · Laboratory Analytical Instruments
ASTROTECH Corp (ASTC) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $13 million. Shares last traded at $7.25, 89.4% below their 52-week high. Over the past year the stock is up 27.2%. Revenue declined 41.2% year over year.
Market Cap
$13M
Shares Out
1.8M
EPS (TTM)
$-0.34
P/E Ratio
—
P/S Ratio
12.65
P/B Ratio
1.05
Dividend / Share
—
Dividend Yield
—
52-Week High
$68.63
52-Week Low
$2.20
Volume
1,026
Avg Vol (3m)
4,093.111
Performance
1W
-0.68%
1M
-18.72%
3M
-82.01%
6M
+129.43%
YTD
+101.11%
1Y
+27.19%
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
RSI (14)
43.00
SMA (50)
$8.27
SMA (200)
$6.87
Price vs SMA50
-12.34%
Price vs SMA200
+5.49%
ATR (14)
$0.82
Financials
Revenue
$1M
Net Income
$-14M
Gross Margin
33.4%
Operating Margin
—
Net Margin
—
Return on Equity
-115.9%
Return on Assets
-87.1%
Current Ratio
6.17
Debt / Equity
0.00
Revenue Growth (YoY)
-41.2%
Latest reported annual period ending 2026-03-31 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| FY 2014 | $0.25 | 2014-09-30 |
| Q3 2014 | $-0.21 | 2014-05-14 |
| Q2 2014 | $-0.07 | 2014-02-14 |
| Q1 2014 | $0.06 | 2013-11-14 |
| FY 2014 | $0.01 | 2014-09-30 |
| Q3 2014 | $-0.12 | 2014-05-14 |
Laboratory Analytical Instruments peers
ASTC vs 14 industry peers (Laboratory Analytical Instruments), by market cap. Updated
P/S vs peers
12.65 / 5.01 med
+153% premium
1–14 of 14
| A | Agilent Technologies | $42.3B | 29.35 | 5.73 | 19.5% | -0.93% |
| WAT | Waters Corporation | $40.6B | 63.24 | 8.75 | 13.8% | +0.36% |
| ILMN | Illumina, Inc. | $33.5B | 40.58 | 7.45 | 18.4% | +3.90% |
| MTD | Mettler Toledo | $27.2B | 30.01 | 6.58 | 21.9% | -0.77% |
| RVTY | Revvity | $14.6B | 61.37 | 5.01 | 8.2% | -0.24% |
| BIO | Bio-Rad Laboratories, Inc. | $10.4B | 46.81 | 4.02 | 8.6% | -0.19% |
| AVTR | Avantor, Inc. | $10.4B | -18.81 | 1.58 | -8.4% | +3.65% |
| BRKR | Bruker Corp | $9.1B | -127.12 | 2.59 | -2.0% | +0.61% |
| TXG | 10x Genomics, Inc. | $8.2B | -108.50 | 13.21 | -12.2% | +2.45% |
| ALMR | Alamar Biosciences, Inc. | $2.1B | — | — | — | +0.51% |
| CTKB | Cytek Biosciences, Inc. | $611M | -9.18 | 2.96 | -32.2% | +0.21% |
| MASS | 908 Devices Inc. | $414M | -11.95 | 6.81 | -57.0% | -3.05% |
| PACB | Pacific Biosciences Of California, Inc. | $403M | -3.06 | — | — | -1.52% |
| EYPT | Eyepoint, Inc. | $394M | -1.28 | — | — | -4.39% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.